Cas:58313-23-8 Ethyl-3-iodobenzoate manufacturer & supplier

We serve Chemical Name:Ethyl-3-iodobenzoate CAS:58313-23-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Ethyl-3-iodobenzoate

Chemical Name:Ethyl-3-iodobenzoate
CAS.NO:58313-23-8
Synonyms:3-ethoxycarbonyl-1-iodobenzene;ETHYL-3-IODOBENZOATE;ethyl 3-iodoethylbenzoate;3-EtO2C-C6H4-I;Benzoic acid, 3-iodo-, ethyl ester;3-Iodobenzoic Acid Ethyl Ester;ETHYL M-IODOBENZOATE;Ethyl 3-iodobenzoate;MFCD00044769;3-iodobenzoic acid methyl ester;Ethyl 3-iodophenylbenzoate
Molecular Formula:C9H9IO2
Molecular Weight:276.071
HS Code:2916399090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:299.3±23.0 °C at 760 mmHg
Density:1.7±0.1 g/cm3
Index of Refraction:1.585
PSA:26.30000
Exact Mass:275.964722
LogP:3.84

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like 3-ethoxycarbonyl-1-iodobenzene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Ethyl 3-iodophenylbenzoate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-ethoxycarbonyl-1-iodobenzene Use and application,3-Iodobenzoic Acid Ethyl Ester technical grade,usp/ep/jp grade.


Related News: Other innovative technology developments have made immobilizing enzymes on solid supports like glass, silicon, or any other polymer more efficient. 4-CHLORO-(α-PHENYL)-CINNAMIC ACID manufacturers In recent years, it has benefited significantly from the development of a broad range of enabling technologies, leading biocatalysis to become an established methodology for efficient, sustainable manufacturing, especially within the drug development industry. 2-(2-ethylphenyl)-N-methyl-1,3-oxazol-4-amine suppliers Novadiscovery (NOVA), a leading health tech company using in silico clinical trials to predict drug efficacy and optimize clinical trial development, today announces the appointment of Grégoire Boutonnet as Chief Operating Officer, effective immediately. 1-O-Palmityl-2-(cis-8,11,14-eicosatrienoyl)-sn-glycero-3-phosphocholine vendor & factory.